Psilocybin reduces symptoms of major depression: The Lancet

Published Date: 04 Mar 2023

A new study by Robin von Rotz and his team found that moderate doses of psilocybin for at least two weeks reduced symptoms of depression...

Read Full News

Latest News

Faricimab May Aid Hard-to-Treat Macular Degeneration Cases

Faricimab may stabilize vision, reduce retinal fluid and thickness, and cut treatment burden in difficult-to-treat cases of wet age-related macular degeneration.

Delays Harmless for Most Macular Degeneration Patients

Waiting for prior authorization of drugs affects a small portion of patients with age-related macular degeneration, resulting in vision loss.

Sri Lanka Uses Air Force Drones to Tackle Spreading Dengue Outbreak

Sri Lanka's public health services and hospitals are battling the worst outbreak of mosquito-borne dengue in nearly a decade, and turning to the island nation's armed...

A 3-Week Steroid Course Falls Short in Pneumonitis

In patients with mild immune-related pneumonitis, a shorter 3-week corticosteroid regimen does not meet noninferiority compared with the standard 6-week taper.

Cefazolin Noninferior to Penicillins for MSSA Bacteremia

Cefazolin is noninferior to antistaphylococcal penicillins for methicillin-susceptible Staphylococcus aureus bacteremia and is associated with a lower risk for acute kidney injury.

Tentacular Cyclosporiasis Outbreak Stymies Epidemiology Efforts

Confirmed case count across 34 states is five times the number reported last summer, the CDC says.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Latest News

Faricimab may stabilize vision, reduce retinal fluid and thickness, and cut treatment burden in difficult-to-treat cases of wet age-related macular degeneration.

Waiting for prior authorization of drugs affects a small portion of patients with age-related macular degeneration, resulting in vision loss.

Sri Lanka's public health services and hospitals are battling the worst outbreak of mosquito-borne dengue in nearly a decade, and turning to the island nation's armed...

In patients with mild immune-related pneumonitis, a shorter 3-week corticosteroid regimen does not meet noninferiority compared with the standard 6-week taper.

Cefazolin is noninferior to antistaphylococcal penicillins for methicillin-susceptible Staphylococcus aureus bacteremia and is associated with a lower risk for acute kidney injury.

Confirmed case count across 34 states is five times the number reported last summer, the CDC says.

News All Time

RSV Preventive Strategies Tied to Fewer Bronchiolitis Cases

Administration of nirsevimab and RSV vaccination in pregnant women are tied to significant reductions in hospitalized days and oxygen requirements among infants with bronchiolitis.

Light Activity Pays Off for COPD Survival

New data show that patients need not exercise intensely to improve outcomes.

Initial Prescription Duration May Shape Benzodiazepine Use

Longer durations of initial prescriptions are associated with prolonged use of benzodiazepines compared with durations of 7 days or less, a large cohort study shows.

Alcohol’s Health Myth Is Over. How to Tell Patients

The science on alcohol has changed dramatically. Here’s how experts say physicians can explain why older advice no longer holds up — and counsel patients without judgment.

US House Committee Opens Investigation Into Merck, AbbVie China Drug Trials

The chair of the U.S. House Select Committee on China opened national security investigations into whether five drugmakers including Merck and AbbVie have been involved in...

Bepirovirsen Achieves Functional Cure in HBV Phase 3 Trial

In patients with chronic hepatitis B infection, bepirovirsen achieves significantly higher rates of functional cure than placebo after discontinuation of nucleoside or nucleotide analog therapy.

Retina Care Visits Reveal High BP in Adults With Diabetes

Many adults with diabetes have uncontrolled or previously undiagnosed high blood pressure during their routine visits to retina clinics, prompting referrals and urgent follow-up, a study finds.

Venezuela Health System Strained After Earthquakes, WHO Says

Venezuela's healthcare system is under significant strain, ⁠the World Health Organization said on Tuesday, with some hospitals damaged and ⁠others missing staff after deadly...

Evidence for tVNS Stronger for Anxiety Than Cognition

Transcutaneous vagus nerve stimulation was associated with reduced anxiety severity but showed no significant benefit for working memory or inhibitory control in healthy adults.

Delirium After Surgery Linked to Lasting Loss of Cognition

Delirium after surgery is associated with lasting decline in cognition in older adults, and rehospitalizations may not explain this association.

RSV More Common Than hMPV in Adults With Chronic Illness

In adults with chronic underlying health conditions, respiratory syncytial virus is detected more often than human metapneumovirus, especially in inpatient settings, a meta-analysis finds.

No Gender Disparity in Deaths After Anaphylaxis

Hospital stay, hospital charges, and other secondary outcomes also were similar between male and female patients.

When AI Makes the Call, Doctors May Take the Blame

For all its promise and computational power, will AI in clinical medicine overcome physicians’ concerns?

New Artificial Neurons Cause Living Brain Cells to Fire

An array of artificial neurons printed on a flexible wafer produce spiking waveforms closely matching biological action — and drive living mouse brain cells to fire.

China Outpacing Europe in Drug Innovation, Pfizer Executive

China has pulled ahead of Europe in pharmaceutical innovation and drug development, a senior Pfizer executive ⁠said on Tuesday.

PCR Testing Finds Infections in Lung Transplant Recipients

Tests show greatest value when used alongside imaging.

Recommended News For You

Hospitalized Kate Middleton; Sen. Paul Demands That Fauci Go To Prison; COVID Returns to Class.

What is Mohs micrographic surgery? 8 FAQs about Mohs

Sports for girls are frequently abandoned due to uniform issues.

Study finds 81% of cancer cures touted by TikTok videos are fake

Breast Cancer Incidence Rises in Asian American Women

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

Distribution of fat could influence cancer risk, study suggests

Recommended Articles For You

Strategic Solutions in Oncology for Modern Medicine 

Macrocytic Anemia: A Comprehensive Review of Pathophysiology, Diagnosis, and Clinical Management 

Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025 

Managing High Potassium Levels: A Comprehensive Guide to Veltassa  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type

2.

The White House has postponed its plan to outlaw menthol cigarettes indefinitely.

3.

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

4.

Significant worldwide disparities seen in availability and timeliness of new cancer drugs

5.

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.

1.

A Clinical Review of Novel Therapeutics for Rare Cancers in the Genomics Era

2.

Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions

3.

Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections

4.

Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances

5.

HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part VIII

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

3.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

4.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot